Stay in the know with #SITC! Explore our upcoming events, webinars, and important dates by looking at our calendar. Learn More: https://sitcancer.org/get-involved/events/calendar#SITC#Immunotherapy

New Journal for ImmunoTherapy of Cancer review: "γδ T cells at the interface of innate and adaptive immunity in cancer" jitc.bmj.com/content/14/3... #JITC #cancer

Read SITC's latest clinical practice guideline published in the Journal for ImmunoTherapy of Cancer to view up-to-date expert recommendations on ICI treatment and management of RCC:https://ow.ly/wEZW50YzbMj Special thanks to Toni Choueiri, MD, Tian Zhang, MD and the full expert panel.

Exciting and timely SITC sponsored “Advances” meeting! @unclineberger.bsky.social

Register for the 2026 EU Immuno-Oncology Drug Development Summit! Explore the best practices for modern IO drug development, including study design, regulatory pathways and emerging technologies. Sept. 3–4 in Lausanne, Switzerland. sitcancer.org/eu-io-summit

Review novel cellular therapy constructs! Join leading experts to discuss logic-gated CAR T cells during SITC's ACI: A Focus on Cellular Therapies program May 22. Learn more: https://www.sitcancer.org/edu/aci/cellular-therapies Krish Patel, MD Allison Betof Warner, MD, PhD

Read SITC’s call to action for development of an ICI irAE RWD registry and best practices for post-ICI survivorship care. View article published in the Journal for ImmunoTherapy of Cancer: https://ow.ly/2GxG50Ywqka #immunotherapy #survivorship

New Journal for ImmunoTherapy of Cancer article: "Intratumoral PD-1-directed IL-2 expression via oncolytic vaccinia virus elicits superior antitumor effects with enhanced safety" jitc.bmj.com/content/14/3... #JITC #immunosky

Rethinking TCHP in HER2+ Early Breast Cancer - Paolo Tarantino @ptarantinomd.bsky.social @medscape.com oncodaily.com/voices/paolo... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #BreastCancer #TCHP #OncoDailyBreast

Thank you to all who joined us for an incredible experience at the 2026 WIC Asia-Pacific Conference! If you enjoyed engaging with our experts and emerging researchers, consider a SITC membership for more mentorship and educational opportunities: https://ow.ly/hvkV50Ym93l

Today is closing day of the #SITC 2026 Spring Scientific. It has been an incredible week. Amazing science, intriguing presentations, powerful keynote address and relationship building through opportunities for networking. A BIG shout out to our organizers! #SITCQuestfor100 #TCells #Immunotherapy

See what is new with SITC by checking out the March edition of the SITC Immune Monitor. Learn about upcoming programs and the most recent society news. Read more here: https://www.sitcancer.org/blogs/sitc-communications/2026/03/27/immune-monitor-march-2026 #CancerIO #SITC #Immune2Cancer

Early-career researchers, shape the future of cancer IO at Tumor Immunology Meets Oncology! Hosted by Brandenburg Medical School Theodor Fontane in collaboration with SITC, May 7–9 in Germany. Present your work & connect with experts. Learn more: https://ow.ly/asIr50YyI7T

#SITC Spring Scientific rolls on with an intriguing presentation from Stephanie Goff, MD, FACS – National Cancer Institute - Taking TIL into the Next Generation More great presentations to follow this afternoon. sitcancer.org/springscientific #SITCQuestfor100 #TIL

Early career investigators! Apply now for a one-year, $50,000 2026-2027 SITC - Merck Cancer Immunotherapy Clinical Fellowship! Letter of Intent due April 15. #SITCFellowship sitcancer.org/fellowships

Comprehensive and updated CPG for RCC! Great for SITC team!

Now published in the Journal for ImmunoTherapy of Cancer — Clinical recommendations from SITC experts on immunotherapy treatment for patients with RCC. View article: https://ow.ly/xhbh50Yz9Hb Toni Choueiri, MD

Congrats to our 2026 #SpringScientific Abstract Awards! The awardees were selected by the program organizers from the top scored abstracts. The awardees are: Camillia Azimi, PhD Nelson Knudsen, PhD Shan Liu, PhD Ayana Ruffin, PhD Luis Sandoval #SITCQuestfor100 @oncodaily.bsky.social

The #SITC #Sparkathon is in the books. What a spectacular group. Big Thanks to our amazing organizers and faculty to make this a career advancing event for the Sparkies! Congratulations Class of 2026! Learn more about Sparkathon: www.sitcancer.org/sparkathon #Mentoring #Gratitude #SITCQuestfor100

Day 1 of the #SITC Spring Scientific ended with the Abstract Poster Session & Networking Reception. So exciting to see all of the research and have discussions with the poster presenters. Learn more about Spring Scientific: www.sitcancer.org/springscient... #SITCQuestfor100 #TCE #Immunotherapy

#SITC Spring Scientific is underway! Welcome everyone to Tucson! Day 1 kicked off with our Keynote speaker Dr. Kristin Hege - presenting: #CAR-T Lessons Learned Guiding Next Gen Cell Therapies. Learn more and register: www.sitcancer.org/springscient... @evanweberphd.bsky.social #SITCQuestfor100

New Journal for ImmunoTherapy of Cancer review: "Role of solute carrier family 7 member 7 in cancer: opportunities for tumor microenvironment research" jitc.bmj.com/content/14/3...

Congratulations to Dr. Paola Nisticò, recipient of the SITC–Lunit Research Program. Her research will explore predictive factors in stage II–III NSCLC using Lunit SCOPE IO–derived immune features and multi-omic data to advance neoadjuvant chemo-immunotherapy. #NSCLC

Learn from experts on post-ICI survivorship care with SITC’s latest article published in the Journal for ImmunoTherapy of Cancer, with guidance on delayed and chronic irAEs. View article: https://ow.ly/OQsP50Ywq8H #immunotherapy #survivorship

Welcome to the 2026 #SITC #Sparkathon participants (Sparkies). We would like to thank them for participating in this unique program to advance their careers in immuno-oncology! #TCells #IO #SITCQuestfor100

SITC seeks applications for two fellowships (@sitcancer.bsky.social) https://cancerletter.com/funding-opportunities/20260320_7a/

There is still time to register and join experts in the IO field at Spring Scientific! Held March 25–27 in Tucson, AZ or virtual. This program will include in-depth discussions of cutting-edge technologies, and the newest clinical studies. Learn more: https://sitcancer.org/edu/2026-spring-scientific

Join leading clinical experts TOMORROW! Focus on the latest updates in IO for breast cancer and receive practical strategies for managing irAEs with a free comprehensive Women’s Malignancies and Breast Cancer program. Register now: https://www.sitcancer.org/edu/aci/womens-malignancies

There are so many reasons to be a #SITC member. From networking with professionals, to advancing the #IO field. Join SITC today and see how a membership can further your career! www.sitcancer.org/join#SITC

Early career investigators! Apply for SITC Fellowship Awards totaling $150,000 by submitting a Letter of Intent (LOI) by April 15. Learn more at sitcancer.org/fellowships #SITCFellowship #IO #grant #funding

Heading to Boston for The American Association of Immunologists #IMMUNOLOGY2026? Join SITC’s cutting-edge session centered on accelerating CAR-based approaches for autoimmunity and cancer! Engage with our experts April 16 and receive the latest updates. Learn more: https://ow.ly/LJVS50YsYFY#IMMUNOLOGY2026?

Deadline approaching! The #SITC Women in Cancer Immunotherapy Network Leadership Institute applications close March 27. Don’t miss your opportunity to participate in panel discussions and presentations from experienced female leaders. Apply today: https://www.sitcancer.org/career-development/win

Now Published: Insights from SITC experts on the surveillance and management of post-ICI delayed or chronic irAEs, including a call for an ICI RWD irAE registry. https://ow.ly/MjP550YwoSO Jarushka Naidoo #immunotherapy #survivorship

There is still time to register and join experts in the IO field at Spring Scientific! Held March 25–27 in Tucson, AZ or virtual. This program will include in-depth discussions of cutting-edge technologies, and the newest clinical studies. Learn more: https://sitcancer.org/edu/2026-spring-scientific

Check out the 2025 Year in Review to discover ways you can get involved with SITC and see what we accomplished last year! #SITCQuestfor100 https://www.sitcancer.org/yearinreview2025/home

SITC Fellowships totaling $150,000 in funding are available now! If you are an early career investigator looking for potential funding opportunities, apply today with a Letter of Intent. Learn more about the fellowships and application process here: http://sitcancer.org/fellowships #SITCFellowship

New Journal for ImmunoTherapy of Cancer article: "Targeting endosomal trafficking-mediated antigen escape to resensitize myeloma to CAR-T therapy" jitc.bmj.com/content/14/3... #JITC #research #ImmunoSky

New Journal for ImmunoTherapy of Cancer review: TCR sequencing in cancer immunology and immunotherapy: what, when, where, why, and how jitc.bmj.com/content/14/3... #JITC #cancer

Implement IO for breast cancer with practical insights from the SITC ACI: A Focus on Women’s Malignancies & Breast Cancer program March 25. Engage with our expert panel and improve patient outcomes. Register now: https://ow.ly/B0cr50YtywB The Breast Cancer Research Foundation Susan G. Komen

The #SITC Women in Cancer Immunotherapy Network Leadership Institute is an initiative seeking to promote and elevate women in the cancer immunotherapy field. Held July 30–31, in Boston, MA or virtually on Sept. 10–11. Apply by March 27. https://www.sitcancer.org/career-development/win

✈️ Don't miss this incredible opportunity! At IMMUNOLOGY2026™, you'll experience world-class science in Boston. Register now and save big on your conference fee. Join us in Boston for a week of unforgettable experiences: immunology2026.aai.org. Early registration ends tomorrow.

Refer a colleague who would benefit from a SITC membership! The top referrer will be honored at #SITC26. Help grow the society and learn more here: www.sitcancer.org/connect-a-colleague#SITC26 #ConnectAColleague

New Journal for ImmunoTherapy of Cancer article: Influence of body composition on the efficacy of nivolumab plus ipilimumab for metastatic clear cell renal cell carcinoma jitc.bmj.com/content/14/3... #JITC #research

Registration is open for the 2026 EU Immuno-Oncology Drug Development Summit! Focus on the next wave of IO therapeutics and ensuring that active, innovative, new therapies are rapidly and appropriately moved into clinical testing. Learn more: sitcancer.org/eu-io-summit

Congratulations to the SITC Postdoctoral Fellowship Awardees recognized at the Translational Research Cancer Centers Consortium 28th Annual Meeting: - Sung Hee Choi, Case CCC - Beatriz Coutinho de Oliveira, Case CCC - Dipyaman Patra, UPMC - Tomomi Sanomachi, Penn Medicine - Anthony Sloan, Case CCC

Connect with emerging researchers and global experts at the 2026 WIC Asia-Pacific Conference March 28–29 in Taipei, Taiwan! Explore the future of IO with SITC and other leading organizations in the region. Learn more: https://ow.ly/k14i50Y5vWA

Special thanks to those who joined our session the #SSO2026 Annual Meeting to explore neoadjuvant IO in surgical oncology! For more directions on implementing cancer IO in the surgical setting, join our ACI session at the Canadian Society of Surgical Oncology. Learn more: https://ow.ly/zS0G50Y3U02

Apply or renew today! #SITC membership connects you to other #IO professionals so you can exchange knowledge and grow your network. https://www.sitcancer.org/join

SITC brings experts together to advance IO! In collaboration with ASTCT, leaders at our 2025 Solid Tumor Summit addressed challenges shaping cell therapy. Read the new manuscript for key insights on regulatory hurdles and tumor heterogeneity: https://ow.ly/vyyF50YpOGs

Today, #SITC joined #OVAC 2026 Lobby Day in DC, with SITC volunteer Dr. Emily Hopewell, advocating for increased funding for the NIH, NCI and the CDC. A BIG thanks to our volunteers & partner organizations for raising their voices & spotlighting the promise of immunotherapy. #SITCQuestfor100